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Summary: This study examines the effect of the whole seed of Garcinia kola (GKS) on various blood 
parameters, in adult male albino rats.  Five groups, of 6 animals per group, were treated by gavage with 
suspensions of graded concentrations of GKS daily for 5 weeks.  The animals were then sacrificed and blood 
was obtained for estimation of the data herein presented.  Packed red cell volume (PCV), hemoglobin 
concentration (Hb), and red blood cell count (RBC) showed significantly (P < 0.05, Student’s t-test) increased 
response to treatment with GKS; while the platelet and white blood cell (WBC) counts showed no 
corresponding increase with increasing GKS dosage.  The mean red blood cell volume (MCV) and mean cell 
hemoglobin (MCH) levels decreased with increasing GKS dosage. Prothrombin time (PT) and activated partial 
thromboplastin time (APPT) were both prolonged with increased GKS dosage; while the serum lipids 
(cholesterol and triglycerides) decreased significantly (P< 0.05, Student’s t-test) with increased GKS dosage. 




One of many plant sources of therapeutic 
ingredient among the people in West and Central 
Africa and some parts of Asia, is the seed plant 
Garcinia kola Heckel (Guttiferae).  It is a 
predominant source of natural materia medica   
employed for the prophylactic management of 
disease (Konoshima et al., 1970).  In the literature 
of ethnopharmacology, Garcinia kola is credited 
with numerous therapeutic applications: poison 
antidote (Dalziel, 1937); treatment of diarrhea, 
hepatitis, asthma, dysmenorrhea or menstrual 
cramps (Dalziel 1956); gonorrhea (Otung, 1990). 
The Garcinia kola seed (“bitter kola”) is 
ingested in relatively large amount at various social 
gatherings; and a number of studies have been done 
while pondering over its possible toxicity in 
humans vis-à-vis the pharmacotherapeutic effects 
of this plant product.  It has been shown that 
chronic ingestion of the “bitter kola” causes 
histological changes in the liver, kidney and 
gastrointestinal tract of rats (Braide 1990; Braide 
and Grill, 1990). Most of the studies on the 
pharmacological activity of phytochemical 
components of Garcinia kola seed, have been on 
the biflavonoids.  These phytochemicals have been 
shown to have a very broad spectrum of 
pharmacological  activity:  protective action against 
chemical induced hemolysis in G6PD deficient 
human red blood cells  (Sharma et al, 2003); anti-
inflammatory antipyretic activity (Braide, 1993; 
Olaleye, 2000) inhibition of hepatic drug 
metabolism (Braide, 1991); antihepatotoxicity 
(Akintonwa and Essien, 1990; Iwu, 1985, Braide, 
1991a; Adegoke et al,1998; Adaramoye and 
Akinloye, 2000; Farombi, 2000; Farombi et al, 
2000); hypoglycaemic anti-diabetic activity (Iwu et 
al, 1990); bronchodilatation in man (Orie and Ekon 
1993); antispasmodic effect on smooth muscle 
(Braide, 1989); anti-thrombotic effect (Olajide, 
1999). 
The objective of this study is to investigate 
the effect of Garcinia kola seed on the erythrocyte 
membrane integrity, hematological cell indices and 
selected coagulation  protein properties.  The 
following questions shall be addressed:  Can the 
“bitter kola” affect erythrocyte membrane 
integrity? This question can be answered, after 
monitoring erythrocyte responses to osmotic 
fragility testing.   Can the “bitter kola” have any 
effect on the extrinsic and intrinsic coagulation 
pathways, as represented by the measure of 
prothrombin time (PT) and activated partial 
thromboplstin time (APTT)?  The answer to this 
question may help to establish any linkages 
between Garcinia kola and the coagulation 
proteins.  What is the effect of Garcinia kola on the 
numbers and concentrations of blood formed 
elements on the one hand, and the hemoglobin 
concentration of the red blood cells on the other 
hand? 
 
Materials and Methods 
Seeds of Garcinia kola 
Garcinia kola seeds were purchased in season 
from markets in Karu and New Wuse, in the 
Federal Capital Territory of Abuja.  Confirmation 
of the plant material was done at the National 
Institute of Pharmaceutical Research and 
Development (NIPRD) Idu, Abuja, Nigeria. 
 
 
Preparation of Seed Samples 
The fresh seeds of Garcinia kola were peeled to 
remove the testa, washed, pelleted and  air-dried for 
8h, then  subsequently dried in an electric oven for 
12h at 30
o
C.  The dry seed pellets were ground to a 
fine powder and stored in a dry glass bottle, from 
which aliquots were reconstituted with distilled  
water to obtain suspensions of appropriate 
concentrations for oral administration. 
 
Animals 
Male Wister albino rats (weighing 200-250g) 
purchased from the National Veterinary Research 
Institute (NVRI) Vom, near Jos, Plateau State, 
Nigeria, were used for this study.  The rats were 
randomly assigned to five groups of six animals 
each, housed in metal cages, and allowed an 
acclimatization period lasting 10 days, prior to use 
for any experiments.  The animals had ad libitum 
access to water and standard laboratory animal feed 
(NIPRD Animal Feed). 
 
Administration of Garcinia kola Seed Powder 
Animals in all groups, excepting the controls, 
received by gavage graded concentrations of 
G.kola seed powder (suspended in distilled water) 
daily for 35 days.  Four doses were administered to 
four different groups of experimental animals 
(300mg/kg, 600mg/kg, 900mg/kg and 1200mg/kg). 
 
Collection and Handling of Blood Samples 
All animals were sacrificed at the end of 35 
days of treatment with G.kola seed powder 
suspension, and whole blood was obtained via 
cardiac puncture.  Aliquots the blood were 
distributed into various suitable containers for 
subsequent analysis as follows: 0.2ml of blood into  
vial containing 0.1mg Na2 EDTA anticoagulant 
[for Hb assay; for counts of various blood cells – 
RBC, WBC,  platelets, differential; and for packed 
cell volume estimation]; 2.5ml of blood into vial 
containing 0.3 ml of 3.2% trisodium citrate [for 
preparation of platelet – poor plasma  (PPP); 2.0ml  
of blood into vial containing Heparin anticoagulant 
[for erythrocyte osmotic fragility test]; and  1.0ml 
of blood into plain vial [for estimation of serum 
cholesterol and triglycerides]. 
 
Estimation of Packed Cell Volume (PCV) 
Blood sample anticoagulated with EDTA was 
made to enter a plain glass capillary tube, one end 
of which was later sealed with non absorbent sealer 
clay.  The tube was then spun at 11,000 rpm for 5 
min in a microhaematocrit centrifuge.  The PCV 
value was then read, using a microhaematocrit 
reader. 
 
Estimation of Blood Cell Parameters 
Haemoglobin (Hb) concentration, red blood cell 
(RBC) count, white blood cell (WBC) count, 
platelet count, mean corpuscular volume (MCV), 
mean cell haemoglobin (MCH) and mean cell 
haemoglobin concentration (MCHC) were 
estimated using a semiautomatic haemotological 
analyzer (SWELAB IEO Model).  The auto counter 
utilized 20µl of blood in 16ml of a commercially 
prepared diluent.  The machine’s ability to count 
cells was based on the principle of electronic 
impedance. 
 
Estimation of Prothrombin time (PT) 
An aliquot (0.1ml) of platelet – poor plasma 
(PPP) sample from each animal was dropped 
individually into test tubes numbered 1 to 30.  
Thereafter, 0.1ml of a commercially prepared 
control sample was dropped into tube number 31.  
All the tubes were warmed at 37
o
C for 3 min (tube 
No. 31 for 5 min).  Subsequently, 0.2ml of 
prothrombin thromboplastin reagent was added to 
each test tube; and the clotting time was recorded 
for each tube. 
 
Estimation of Activated Partial Thromboplastin 
time (APPT) 
An aliquot (0.1ml) of APTT reagent (Darlez 
Nig. Ltd, Abuja) was added to a pair of test tubes 
(one containing a test sample and the other serving 
as control).  The tubes were incubated at 37
o
C for 
5min, before adding 0.1ml CaCl2 solution (Darlez 
Nig. Ltd, Abuja).  The clotting time was noted. 
 
Ertythrocyte Osmotic Fragility Test 
This test was done on all rats in each group; and 
blood samples collected in heparinised vials were 
analyzed within 3h of collection.  A commercially 
prepared 10% buffered saline working solution was 
used.  The red blood cell sample was washed three 
times in isotonic saline, after which 0.02ml of each 
washed cell sample was placed in eight graded 
concentrations of working saline solution [0.1%, 
0.25%, 0.30%, 0.35%, 0.40%, 0.55%, 0.65% and 
0.85] and incubated at 37
o
C for 30min, then 
centrifuged for 5min.  The optical absorbance of 
each supernatant was then measured, using a 
colorimeter, at 540nm wavelength.  The percentage 
haemolysis was calculated, for each of the blood 
samples obtained, and used to develop an 
osmograph for evaluating the osmotic fragility. 
 
Estimation of Serum Cholesterol 
The enzymatic estimation of serum cholesterol 
was done using a chemistry analyzer (Humalyser 
2000).  The basic principle is dependent on 
enzymatic hydrolysis and oxidation of cholesterol 
to produce red quinoximine, the color intensity of 
which is proportional to the total serum cholesterol, 
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Results 
Treatment, by gavage, with pulverized Garcinia 
kola seed (GKS) produced various effects on blood 
parameters in albino rats.  These effects included 
changes in hematological indices (Hb, PCV, MCV, 
MCH and MCHC, RBC, WBC, PT APPT); 
alterations in blood chemistry (serum cholesterol 
and tryplyceride) and Erythrocyte hemolysis in 
various concentrations of hypotonic saline 
solutions [an indication of degree of osmotic 
fragility]; all of which appeared to be dose-
dependent. 
Rats treated with various doses of GKS showed 
significant (p<0.05, Student’s t-test) dose-
dependent increase in haemoglobin (Hb) 
concentration, packed cell volume (PCV) and mean 
corpuscular haemoglobin concentration (MCHC).  
On the other hand, the mean cell volume (MCV) 
and mean cell haemoglobin (MCH) showed a dose-
dependent depreciation (Table 1). Rats that 
received GKS at doses of 600mg/kg, 900mg/kg and 
1200mg/kg, respectively exhibited significant 
(p<0.05, Student’s t-test) increments in red blood 
cell (RBC) count, but the platelet numbers 
depreciated significantly (p<0.05, Student’s t-test).  
(Table 2).  
Representative parameters of the blood 
coagulation mechanism investigated in this study, 
namely, prothrombin time (PT) and activated 
partial thromboplastin time (APPT), indicated that 
both PT and APPT exhibited dose-dependent 
increases (Table 3).  The effect of GKS therapy on 
serum cholesterol and triglyceride was a dose-
dependent decrease in these parameters (Table 4). 
 
Effect of GKS therapy on Erythrocyte Osmotic 
Fragility  
Erythrocytes of the untreated control rats 
(0mg/kg GKS) exhibited the earliest sign of 
haemolysis in 0.65% NaCl solution; whereas the 
erythrocytes from rats that received GKS therapy at 
doses of 300mg/kg and 600mg/kg exhibited 5% 
and 3% haemolysis when placed into 0.55% NCl 
solution.  A corresponding onset of haemolysis in 
rats that received GKS therapy at doses of 
900mg/kg and 1,200mg/kg was observed when the 
representative erythrocytes were placed in 0.40% 
NaCl solution and 0.35% NaCl solution, 
respectively. At 0.1% NaCl solution, the 
erythrocytes from all groups, including untreated 
controls, exhibited 100% haemolysis. 
 









a =significantly difference from control (p< 0.5, Student’s t-test) 
 







a = significantly different from control (p <0.05, Student’s t-test). 
 
 
Table 3: Mean values of PT & APPT for graded doses of GSK Powder Administered among groups. 
 
Index Dose of GKS powder 
 Control 300mg/kg 600mg/kg 900mg/kg 1200mg/kg 
PT 6.13 + 0.32 7.63 + 0.49
 a
 8.58 + 0.22
 a
 8.35 + 0.30
 a
 9.62 + 0.52
 a
 
APPT 16.47 +  2.77 19.65 +  0.95 21.28 +  52
 a
 21.92 +  0.75
 a
 23.27 +  0.73
 a
 






Index Dose of GKS powder 
 Control 300mg/kg 600mg/kg 900mg/kg 1200mg/kg 
HB 12.34+ 0.17 12.87+ 0.16 13.28 + 0.12
a   
 13.48 + 0.11




PCV 45.34+ 0.55 45.83+ 0.44 47.12 + 0.24
a  
 47.65 + 0.25




MCV 64.80+ 0.97 61.83+ 1.40 61.6 + 0.16
a    
 60.63 + 0.09




MCH 17.71 + 0.22 17.30 + 0.33 17.25 + 0.35 16.80 + 9.41      17.26 + 0.15 
MCHC 27.25 + 0.48 28.01 + 0.40 28.29 + 0.32 28.55 + 0.25      28.36+ 0.43 
Index Dose of GKS powder 
 Control 300mg/kg 600mg/kg 900mg/kg 1200mg/kg 
RBC 6.99.0.09 7.46 + 0.17
a
 7.72 + 0.15
 a
 7.87 + 0.160
 a
 8.32 + 0.14
 a
 
WBC 81.67 + 7.25 81.67 + 6.17 79.33 +  5.63 81.5 + 4.25 78.00 + 4.04 
Platelets 686.67 + 9.34 636.67+ 25.71 618.17 + 25.24 692 + 21.51 677.67 + 23.63 





Table 4: Mean values of triglycerides and cholesterol for graded doses of GKS administered among groups. 
Index Dose of GKS powder 
 Control 300mg/kg 600mg/kg 900mg/kg 1200mg/kg 
Triglyceride 1.23 + 0.13 0.98 + 0.11 0.94 + 0.10
 a
 0.76 + 0.07
 a
    0.75 + 0.15
a
 
Cholesterol 5.98 + 0.16 5.39 + 0.39 5.39 + 0.28
 a
 4.86 + 0.35
 a
    4.60 + 0.33
a
 
a = significantly different from control (p<0.05, Student’s t-test). 
 
 





 Group A Group B Group C Group D Group E 
0.1 100 100 100 100 100 
0.25 100 100 98 98 96 
0.3 85 65 63 60 45 
0.35 50 30 30 20 10 
0.4 30 10 10 5 0 
0.55 9 5 3 0 0 
0.65 5 0 0 0 0 
0.85 0 0 0 0 0 
 
Discussion 
The effects of GKS on PCV, Hb and RBC were 
dose-related; and were observed to be more intense 
at higher doses of GKS medication.  The effect on 
Hb appeared to be the most sensitive to GKS and 
was observed at a dose (300mg/kg) which had no 
apparent effect on either PCV or RBC; GKS effects 
on PCV and RBC were manifested at a higher dose 
(600mg/kg).  The phenomenon regulating this 
disparity in dose-response relationship regarding 
these erythropoietic indices is not well understood.  
There is a possibility that early interaction of GKS 
constituents with haematopoietic sites of action 
may activate haemoglobin production before 
influencing haematocyte preservation; in view of 
the fact that redox  metabolism involving oxygen 
radicals regulates many physiological activities 
such as signaling, proliferation and apoptosis.  The 
mitigation of these activities, by GKS, at diverse 
points or to varying degrees can introduce such 
disparity in PCV, Hb and RBC presentations.  One 
established consequence of GKS medication is its 
antioxidant activity which complements the action 
of reduced glutathione produced via a metabolic 
pathway (pentose monophosphate shunt) in the 
erythrocyte.  The essence of this antioxidant 
activity is the redox cascade which ultimately 
maintains the haeme iron in its ferrous state vis-à-
vis the ferric state that is associated with production 
of defective methaemoglobin.  The direct link 
between antioxidant activity and haemoglobin 
quality and/or quantity was shown by the  
observation that ascorbic acid supplementation, via 
its action as a free radical scavenger, increased 
significantly the haemoglobin levels in children 
suffering from sickle cell anaemia (Jaja et al., 
2002). 
Whereas the erythropoietin modulated 
haemocyte lines showed  increases in response to 
increasing GKS dosage, the white blood cells and 
platelets did not  show any significant enhancement 
in numbers.  This suggests that the GKS action 
relating to increase in blood cell lines may be 
effected through an influence on the stimulant 
cytokine erythropoietin.  However, it should be 
noted that the peripheral blood leukocytes, as 
counted in this study, is only a small fraction of 
total body leukocyte pool.  Additional leukocyte 
depots include the bone marrow and other body 
organs. 
There was clearly a depreciation of the mean 
cell volume (MCV) with an increase in GKS 
dosage, implying that the cell size decreases 
significantly as dosage of medication was increased 
(from 300mg/kg to 900mg/kg and 1200mg/kg).  
This decrease can possibly be accounted for by the 
increase of mature erythrocytes relative to the 
larger immature forms (erythroblasts) due to the 
protective antioxidant action of GKS constituents 
(especially the biflavonoids like kolaviron).  The 
interplay of protective actions, such as redox 
modulation of erythropoietin production, absence 
of anaemia or hypoxia and delayed release of 
reticulocytes into peripheral blood, ensures an 
aggregate decrease in MCV (Bunn, 1972).  The 
decrease in MCV can also be attributed to possible 
functional deficiency of elemental iron, ostensibly 
facilitated by accelerated mobilization of iron 
stores, without concurrent iron supplementation in 
the diet.  But the iron mobilization effect of 
ascorbic acid is defective, with a baseline value of 
less than 10% for hypochromic red cells (Sezer et 
al., 2002).  This supports the observed significant 
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rise in MCHC at a dosage of only 300mg/kg; 
considering the decreases in MCH at doses of 
300mg/kg, 900mg/kg and 1200mg/kg, signifying 
the consequence of depreciating iron stores.  This 
depreciation was not low enough to reverse 
concurrent increases in PCV and Hb at the said 
doses of GKS. 
GKS redication had no apparent effect on 
platelet counts; but there were significant dose-
dependent increases in PT and APTT, compared to 
untreated controls.  This is a remarkable reflection 
of anti aggregation ability typical of antioxidants.  
Aspirin was shown to decrease platelet activation 
in vivo during arterial thrombosis and cause a 
counterpart decrease in prothrombin activation in 
vivo (Ross et al., 1985). In the study herein 
presented, the increase in PT may be related to 
decreased platelet activation caused by 
antiaggregation effect of antioxidants in Garcinia 
kola seeds.  However, some in vivo oxidants have 
been shown to increase prothrombin time, through 
another direct anticoagulant action.  Stief et al., 
(2000) stated that blood coagulation factors I.V, 
VIII and X as well as platelets are sensitive to 
nonradical singlet oxygen –derived oxidants 
originating from activated polymorphonuclear 
leucocytes. 
These chloramine – type oxidants were seen to 
act as anticoagulants in human plasma, prolonging 
PT, APTT and the thromboplastin time, at 
chloramine concentrations greater than 1mmol/l. In 
the absence of any pathological condition leading 
to observed increase in phagocyte activation in the 
animals used in this study, the increased PT and 
APTT values are attributable almost exclusively to 
the antiplatelet aggregation potentials of 
constituents in GKS, or their vitamin E-like 
prevention of oxidation of reduced vitamin K.  
Oxidation leads to carboxylation of vitamin K-
dependent clotting factors, thus affecting their 
maximal functionality (Knight, 1995). 
Serum cholesterol and triglyceride values were 
markedly decreased with increasing dosage of 
GKS.  This observation is reminiscent of the action 
of some dietary isoflavones (eg., soy bean 
isoflavones) that have been observed to decrease 
the levels of total plasma lipids, total cholesterol 
and triglyceride (Yousef et al., 2004). 
Chemical oxidative actions have been shown to 
exert haemolytic influence through lipid 
peroxidation of the red blood cell membrane and 
interference with metabolic activities that ensure 
the cell’s integrity.  Ascorbic acid, a known 
antioxidant, was shown to prevent oxidative 
damage of the cell membrane (Jaja et al., 2002); 
and vitamin C supplementation reduced erythrocyte 
lyses at 50% NaCl concentration, compared to 
controls in an osmotic fragiligram.  These 
observations are similar to that reported in this 
study for GKS, showing that the antioxidant 
activities of constituents in Garcinia kola seeds can 
be protective against cell lysis. 
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